You are invited to submit your oral and poster abstracts for the next Cannabis Science Conference taking place in Providence, Rhode Island, on September 20-22!
Share your research or best practices with your peers! Submit your abstract here by Monday, June 12th, 2023 for consideration!
All oral and poster abstract submissions must be made electronically through the conference’s online abstract submission system.
Your abstract should be a short description of your work and contain all the elements necessary to define your goals and results to the reader.
Categories of submission include the following:
The review committee will evaluate the scientific or medical quality of the submitted abstracts based on the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed. All PDF abstract submissions must include the abstract title, co-authors listed, the full abstract, and indicate if this is an encore presentation and, if so, where it was previously presented.
Notification of acceptance or regret will be delivered via email to the presenter(s) of each abstract by June 30, 2023.
If accepted for presentation, oral submissions will take place in our Analytical, Medical, Cultivation or Psychedelic tracks/session rooms. The posters will be displayed in the exhibit hall for the length of the conference, attendance is required at the event. The presentation at the 2023 Cannabis Science Conference Fall should reflect the submitted abstract, abstract title, authorship, and content. All accepted presenters will be automatically registered to attend the conference and will also be provided with a plus one complimentary registration to bring a guest.
Submission Process
Please submit any questions pertaining to abstract submissions to info@mjhlifesciences.com using the subject line "2023 CSC Fall Abstract QUESTION."
Author Consent and Waiver of Claims
Abstract Format
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.